Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.

Karagoz K, Mehta GA, Khella CA, Khanna P, Gatza ML

Open source

DOI
10.1016/j.ebiom.2019.11.009
Published
2019 Dec
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2019.11.009,
  title = {Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.},
  author = {Karagoz K and Mehta GA and Khella CA and Khanna P and Gatza ML},
  year = {2019},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2019.11.009},
  url = {https://doi.org/10.1016/j.ebiom.2019.11.009}
}

RIS

TY  - JOUR
TI  - Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.
AU  - Karagoz K
AU  - Mehta GA
AU  - Khella CA
AU  - Khanna P
AU  - Gatza ML
PY  - 2019
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2019.11.009
UR  - https://doi.org/10.1016/j.ebiom.2019.11.009
ER  - 

APA

K, K., GA, M., CA, K., P, K., & ML, G. (2019). Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2019.11.009

Source records